| Literature DB >> 18371210 |
Mika Venojärvi1, Sirkka Aunola, Raivo Puhke, Jukka Marniemi, Helena Hämäläinen, Jukka-Pekka Halonen, Jaana Lindström, Merja Rastas, Kirsti Hällsten, Pirjo Nuutila, Osmo Hänninen, Mustafa Atalay.
Abstract
BACKGROUND: Insulin resistance and diabetes are associated with increased oxidative stress and impairment of cellular defence systems. Our purpose was to investigate the interaction between glucose metabolism, antioxidative capacity and heat shock protein (HSP) defence in different skeletal muscle phenotypes among middle-aged obese subjects during a long-term exercise and dietary intervention. As a sub-study of the Finnish Diabetes Prevention Study (DPS), 22 persons with impaired glucose tolerance (IGT) taking part in the intervention volunteered to give samples from the vastus lateralis muscle. Subjects were divided into two sub-groups (IGTslow and IGTfast) on the basis of their baseline myosin heavy chain profile. Glucose metabolism, oxidative stress and HSP expressions were measured before and after the 2-year intervention.Entities:
Year: 2008 PMID: 18371210 PMCID: PMC2330145 DOI: 10.1186/1472-6823-8-3
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
Baseline characteristics of the subjects with impaired glucose tolerance (IGT) divided into the slow and fast fibre type sub-groups.
| Characteristics | IGTslow | IGTfast |
| 10 (4/6) | 12 (2/10) | |
| Age, yr | 58.5 ± 2.0 | 54.1 ± 2.0 |
| BMI (kg/m2) | 29.9 ± 0.7 | 29.9 ± 0.7 |
| Weight, kg | 86.9 ± 2.8 | 92.0 ± 2.2 |
| MHC I, % | 46.4 ± 2.9 | 30.6 ± 1.0*** |
| MHC IIa, % | 36.9 ± 3.5 | 47.2 ± 2.0** |
| MHC IIx, % | 16.7 ± 3.3 | 22.2 ± 2.1 |
| Fp-glucose, mmol/l | 6.0 ± 0.2 | 6.0 ± 0.1 |
| 2h-glucose, mmol/l | 7.8 ± 0.3 | 7.5 ± 0.5 |
| Fs-insulin, μU/ml | 12.9 ± 1.0a | 19.5 ± 2.7* b |
| 2 h-insulin, μU/ml | 72 ± 13a | 117 ± 35b |
| HbA1c, % | 5.7 ± 0.1 | 5.7 ± 0.1 |
| HOMA-IR | 3.5 ± 0.3a | 5.2 ± 0.7b |
Data are given as means ± SE; * P < 0.05; ** P < 0.01, *** P < 0.001 a n = 9, b n = 11, Kruskall-Wallis test for difference between the groups.
Indices of glucose m etabolism, weight, m axim al oxygen uptake and oxidative stress in the subjects with im paired glucose tolerance (IGT), n = 22.
| Baseline | 2-year follow-up | Change | ||
| Fp-glucose, m m ol/l | 6.0 ± 0.1 | 5.8 ± 0.1 | -0.3 ± 0.1 | 0.013 |
| 2h-glucose, m m ol/l | 7.7 ± 0.3 | 6.4 ± 0.4 | -1.2 ± 0.5 | 0.013 |
| HbA1c, % | 5.7 ± 0.1 | 5.4 ± 0.1 | -0.4 ± 0.1 | <0.001a |
| W eight, kg | 89.7 ± 1.8 | 85.3 ± 2.0 | -4.4 ± 1.1 | <0.001 |
| BM I (kg/m2) | 29.9 ± 0.5 | 28.4 ± 0.5 | -1.5 ± 0.4 | <0.001 |
| VO2max, l/min | 2.28 ± 0.14 | 2.43 ± 0.13 | 0.2 ± 0.0 | <0.001 |
| VO2max/weight, ml/kg/min | 26.1 ± 1.6 | 28.5 ± 1.5 | 2.4 ± 0.6 | <0.001 |
| GRP75 (muscle), arb. u. | 0.95 ± 0.11 | 1.28 ± 0.16 | 0.33 ± 0.12 | 0.014 |
| HSP60 (muscle), arb. u. | 0.35 ± 0.05 | 0.56 ± 0.11 | 0.21 ± 0.08 | 0.022 |
| P. carbonyls (serum), arb. u. | 0.12 ± 0.00 | 0.11 ± 0.00 | -0.00 ± 0.00 | 0.010b |
| Uric acid, μmol/l | 375 ± 12 | 337 ± 14 | -37 ± 9 | 0.001 |
Data are given as m eans ± SE; arb. u. = arbitrary units, a n = 21, b n = 20
Indices of glucose m etabolism and oxidative stress from serum and skeletal m uscle sam ples, as well as m axim al oxygen uptake in the subjects with im paired glucose tolerance (IGT) divided into two muscle phenotype groups.
| IGTslow subjects Baseline | 2-year follow-up | IGTfast subjects Baseline | 2-year follow-up | |
| 10 (4/6) | 12 (2/10) | |||
| HbA1c, % | 5.74 ± 0.13 | 5.38 ± 0.08* | 5.67 ± 0.11 | 5.33 ± 0.14** |
| HOM A-IR | 3.52 ± 0.30 | 3.22 ± 0.51 | 5.23 ± 0.75 | 3.77 ± 0.71* |
| ORAC, μmol | 56.0 ± 4.5 | 58.2 ± 3.1 | 54.0 ± 3.4 | 55.4 ± 3.2 |
| P. carbonyl, arb.u. | 0.129 ± 0.005 | 0.126 ± 0.00 | 0.110 ± 0.003## | 0.106 ± 0.003* ## |
| Uric acid, μmol/l | 370 ± 17 | 331 ± 18** | 379 ± 17 | 342 ± 21* |
| P. carbonyl, arb.u. | 0.074 ± 0.011 | 0.071 ± 0.008 | 0.072 ± 0.007 | 0.070 ± 0.005 |
| 4-HNE, arb.u. | 0.29 ± 0.07 | 0.24 ± 0.04 | 0.25 ± 0.04 | 0.26 ± 0.04 |
| VO2max, l/min | 1.96 ± 0.22a | 2.10 ± 0.20* a | 2.52 ± 0.15 | 2.69± 0.15** |
| VO2max, /weight ml/kg/min | 23.3 ± 2.7a | 25.3 ± 2.4* a | 28.2 ± 1.7 | 30.9 ± 1.6** |
Data are given as means ± SE; *P < 0.05, ** P < 0.01 within group; #P < 0.05, ##P < 0.01 between groups;a n = 9.
Figure 1Dietary vitamin C and E intakes during a 2-year intervention in subjects with impaired glucose tolerance (IGT), divided into slow (n = 10) and fast (n = 12) fibre type sub-groups.
Figure 2(A) Effects of the 2-year intervention on the protein expression of GRP75 and HSP60 in the Data are given as means ± SE. *P < 0.05 within groups. (B) Representative Western blots, using anti-GRP75 and beta-actin antibodies, of whole tissue homogenates from skeletal muscle biopsies of four IGT subjects at baseline (0) and after 2-year follow-up (2).
Figure 3(A) Effects of the 2-year intervention on the protein expression of HSP72 and HSP90 in the Data are given as means ± SE. *P < 0.05 within groups. (B) Representative Western blots, using anti-HSP72 and beta-actin antibodies, of whole tissue homogenates from skeletal muscle biopsies of four IGT subjects at baseline (0) and after 2-year follow-up (2).
Figure 4Relationship between the changes of the HSP60 and ORAC values during a 2-year intervention in subjects with impaired glucose tolerance (IGT), divided into slow (n = 8) and fast (n = 12) fibre type sub-groups.
Figure 5Relationship between the changes of the GRP75 and VO2max values during a 2-year intervention in subjects with impaired glucose tolerance (IGT), divided into slow (n = 9) and fast (n = 12) fibre type sub-groups.